1. Home
  2. DEC vs ZYME Comparison

DEC vs ZYME Comparison

Compare DEC & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEC
  • ZYME
  • Stock Information
  • Founded
  • DEC 2001
  • ZYME 2003
  • Country
  • DEC United States
  • ZYME United States
  • Employees
  • DEC N/A
  • ZYME N/A
  • Industry
  • DEC
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • DEC
  • ZYME Health Care
  • Exchange
  • DEC Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • DEC 849.3M
  • ZYME 867.6M
  • IPO Year
  • DEC N/A
  • ZYME 2017
  • Fundamental
  • Price
  • DEC $14.90
  • ZYME $13.33
  • Analyst Decision
  • DEC Strong Buy
  • ZYME Buy
  • Analyst Count
  • DEC 4
  • ZYME 7
  • Target Price
  • DEC $20.75
  • ZYME $19.50
  • AVG Volume (30 Days)
  • DEC 417.3K
  • ZYME 490.0K
  • Earning Date
  • DEC 01-01-0001
  • ZYME 08-07-2025
  • Dividend Yield
  • DEC 5.46%
  • ZYME N/A
  • EPS Growth
  • DEC N/A
  • ZYME N/A
  • EPS
  • DEC N/A
  • ZYME N/A
  • Revenue
  • DEC $758,798,000.00
  • ZYME $93,384,000.00
  • Revenue This Year
  • DEC $46.42
  • ZYME $44.71
  • Revenue Next Year
  • DEC $9.54
  • ZYME $34.57
  • P/E Ratio
  • DEC N/A
  • ZYME N/A
  • Revenue Growth
  • DEC N/A
  • ZYME 85.05
  • 52 Week Low
  • DEC $10.08
  • ZYME $9.03
  • 52 Week High
  • DEC $17.70
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • DEC 56.77
  • ZYME 49.83
  • Support Level
  • DEC $14.71
  • ZYME $13.98
  • Resistance Level
  • DEC $15.15
  • ZYME $15.00
  • Average True Range (ATR)
  • DEC 0.32
  • ZYME 0.59
  • MACD
  • DEC 0.01
  • ZYME -0.01
  • Stochastic Oscillator
  • DEC 75.38
  • ZYME 25.11

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: